Applied Biologics, a biopharmaceutical company advancing novel biologic therapies for chronic wounds, tissue repair, and degenerative disease, presented interim clinical data from the CAMPX Trial at ...

Oral GLP-1 medications have the potential to increase access to therapies that can help lower blood sugar and reduce ...

A randomized clinical trial conducted across five countries in 47 pediatric emergency departments, including Ann & Robert H.

Serial KCCQ-TSS decline emerged as the most prominent pre-event signal for sudden death, contrasting with improving symptoms ...

Peer-reviewed randomized controlled trial of 427 adults found that after completing Noom’s 16-week program, members continued ...

The 2026 ASCO annual meeting featured a prostate cancer trials in progress session and a presentation by Dr. Michael Ong discussing TRIPLE-SWITCH (SWOG/CCTG-PR26), a randomized phase III clinical ...

Primary analyses showed no significant differences between the semaglutide and placebo groups in laboratory measures of ...

Actuate Therapeutics, Inc. (NASDAQ: ACTU), a clinical-stage biopharmaceutical company focused on developing novel therapies for difficult-to-treat cancers, today announced that elraglusib will be ...

BRUIN CLL-313 is a randomized, open-label, global phase III study comparing the efficacy and safety of pirtobrutinib, a highly selective, noncovalent Bruton tyrosine kinase inhibitor (BTKi), against ...

The aim of this research therefore was to streamline the understanding of typical causal structures in both randomized and nonrandomized clinical trials in oncology, presenting concise guidelines for ...